Scientists summarize the most recently developed broad-spectrum fusion inhibitors, such as neutralizing antibodies, peptides, proteins, and small-molecule compounds, and candidate vaccines targeting the conserved elements in SARS-CoV-2 S2 subunit.
[Signal Transduction And Targeted Therapy]